✦ LIBER ✦

PCN50 COST-EFFECTIVENESS OF DOCETAXEL PLUS CYCLOPHOSPHAMIDE VERSUS DOXORUBICIN PLUS CYCLOPHOSPHAMIDE IN THE ADJUVANT TREATMENT OF OPERABLE BREAST CANCER

✍ Scribed by S Jones; L Chen; M Tangirala; L Asmar; P Airia; MF Thompson

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN91 LONG TERM COST-EFFECTIVENESS OF DO

✍ D Jackson; JM Lee; J Adams; A Gordois 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

Adjuvant docetaxel plus doxorubicin and

✍ Vivek Roy; Edith A. Perez 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Cost–effectiveness analysis of adjuvant

✍ Sang Gyu Lee; Young Geon Jee; Hyun Chul Chung; Sung-Bae Kim; Jungsil Ro; Young-H 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 231 KB

PCN12 IMPACT OF ADJUVANT CHEMOTHERAPY WI

✍ H Miadi-Fargier; C Le Pen; MC Woronoff-Lemsi; JP Guastalla; X Pivot; H Roché; F 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

Cost-effectiveness analysis of adjuvant

✍ Heather-Jane Au; Kamran Golmohammadi; Tallal Younis; Shailendra Verma; Stephen C 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 307 KB

P180 A cost effectiveness analysis of ad

✍ B.L. Rapoport; S.D. Moodley; C. Jacobs; R. Pienaar; S. Fourie; W.M. Szpak 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 44 KB